Product Images Restasis
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Restasis NDC 0023-9163 by Allergan, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The following structure for RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% contains a topical calcineurin inhibitor immunosuppressant with anti-inflammatory effects. Cyclosporine’s chemical name is Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]. - restasis 01
![The following structure for RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% contains a topical calcineurin inhibitor immunosuppressant with anti-inflammatory effects. Cyclosporine’s chemical name is Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]. - restasis 01](https://ndclist.com/assets/spl/images/8e24af2b-bc1c-4849-94f2-6df950cdca89/restasis-01.jpg "restasis-01.jpg")
Allergan - restasis 02
PRINCIPAL DISPLAY PANELNDC 0023-9163-60 No. 94529Restasis® (Cyclosporine Ophthalmic Emulsion) 0.05%60 Single-Use Vials (0.4 mL each) One Month Supply Sterile, Preservative-Free - restasis 03
Restasis is a prescription drug used to treat chronic dry eye. The drug comes in the form of single-use vials, with 60 vials in each package. Each vial contains 0.4 ml of the solution, which is sterile and free of preservatives. The active ingredient in Restasis is 0.05% cyclosporine, and the solution also contains glycerin, castor oil, polysorbate 180, carbomer copolymer type A, purified water, and sodium hydroxide to adjust the pH. Restasis should be used twice daily, approximately 12 hours apart. Each vial should be inverted before use and should be used immediately after opening. Restasis vials should be stored in the thermoformed tray until use, and the entire contents of each package should be discarded after one month.*
restasis 04
Restasis is a prescription medication that comes in the form of single-use vials, with each vial containing 0.4 mL of sterile and preservative-free solution. The solution is made up of active ingredient cyclosporine (0.05%) and other ingredients such as glycerin, castor oil, and purified water. This medication is used to treat chronic dry eye and is to be used twice daily with approximately 12 hours apart. The vial should be inverted before usage and discarded immediately after opening. It should be stored at a cool temperature of 15°-25°C (59°-77°F) in the thermoformed tray until use. This product is patented and manufactured in the USA by Allergan.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.